53 related articles for article (PubMed ID: 8753809)
1. The natural product noformycin is an inhibitor of inducible-nitric oxide synthase.
Green BG; Chabin R; Grant SK
Biochem Biophys Res Commun; 1996 Aug; 225(2):621-6. PubMed ID: 8753809
[TBL] [Abstract][Full Text] [Related]
2. Active-site structure analysis of recombinant human inducible nitric oxide synthase using imidazole.
Chabin RM; McCauley E; Calaycay JR; Kelly TM; MacNaul KL; Wolfe GC; Hutchinson NI; Madhusudanaraju S; Schmidt JA; Kozarich JW; Wong KK
Biochemistry; 1996 Jul; 35(29):9567-75. PubMed ID: 8755738
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of new sulfur-containing L-arginine-derived inhibitors of nitric oxide synthase.
Ichimori K; Stuehr DJ; Atkinson RN; King SB
J Med Chem; 1999 May; 42(10):1842-8. PubMed ID: 10346937
[TBL] [Abstract][Full Text] [Related]
4. Structural requirements for human inducible nitric oxide synthase substrates and substrate analogue inhibitors.
Grant SK; Green BG; Stiffey-Wilusz J; Durette PL; Shah SK; Kozarich JW
Biochemistry; 1998 Mar; 37(12):4174-80. PubMed ID: 9521739
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of nitric oxide synthase isoforms by porphyrins.
Wolff DJ; Naddelman RA; Lubeskie A; Saks DA
Arch Biochem Biophys; 1996 Sep; 333(1):27-34. PubMed ID: 8806750
[TBL] [Abstract][Full Text] [Related]
6. Ni(2+), a double-acting inhibitor of neuronal nitric oxide synthase interfering with L-arginine binding and Ca(2+)/calmodulin-dependent enzyme activation.
Palumbo A; Astarita G; Picardo M; d'Ischia M
Biochem Biophys Res Commun; 2001 Jul; 285(1):142-6. PubMed ID: 11437384
[TBL] [Abstract][Full Text] [Related]
7. BYK191023 (2-[2-(4-methoxy-pyridin-2-yl)-ethyl]-3h-imidazo[4,5-b]pyridine) is an NADPH- and time-dependent irreversible inhibitor of inducible nitric-oxide synthase.
Tiso M; Strub A; Hesslinger C; Kenney CT; Boer R; Stuehr DJ
Mol Pharmacol; 2008 Apr; 73(4):1244-53. PubMed ID: 18178668
[TBL] [Abstract][Full Text] [Related]
8. Substrate and substrate analog binding to endothelial nitric oxide synthase: electron paramagnetic resonance as an isoform-specific probe of the binding mode of substrate analogs.
Salerno JC; Martásek P; Williams RF; Masters BS
Biochemistry; 1997 Sep; 36(39):11821-7. PubMed ID: 9305973
[TBL] [Abstract][Full Text] [Related]
9. The inhibitory potency and selectivity of arginine substrate site nitric-oxide synthase inhibitors is solely determined by their affinity toward the different isoenzymes.
Boer R; Ulrich WR; Klein T; Mirau B; Haas S; Baur I
Mol Pharmacol; 2000 Nov; 58(5):1026-34. PubMed ID: 11040050
[TBL] [Abstract][Full Text] [Related]
10. N-Phenylamidines as selective inhibitors of human neuronal nitric oxide synthase: structure-activity studies and demonstration of in vivo activity.
Collins JL; Shearer BG; Oplinger JA; Lee S; Garvey EP; Salter M; Duffy C; Burnette TC; Furfine ES
J Med Chem; 1998 Jul; 41(15):2858-71. PubMed ID: 9667974
[TBL] [Abstract][Full Text] [Related]
11. 2-Iminopyrrolidines as potent and selective inhibitors of human inducible nitric oxide synthase.
Hagen TJ; Bergmanis AA; Kramer SW; Fok KF; Schmelzer AE; Pitzele BS; Swenton L; Jerome GM; Kornmeier CM; Moore WM; Branson LF; Connor JR; Manning PT; Currie MG; Hallinan EA
J Med Chem; 1998 Sep; 41(19):3675-83. PubMed ID: 9733492
[TBL] [Abstract][Full Text] [Related]
12. Aromatic reduced amide bond peptidomimetics as selective inhibitors of neuronal nitric oxide synthase.
Hah JM; Martásek P; Roman LJ; Silverman RB
J Med Chem; 2003 Apr; 46(9):1661-9. PubMed ID: 12699384
[TBL] [Abstract][Full Text] [Related]
13. Evidence that inducible nitric oxide synthase is involved in LPS-induced plasma leakage in rat skin through the activation of nuclear factor-kappaB.
Iuvone T; D'Acquisto F; Van Osselaer N; Di Rosa M; Carnuccio R; Herman AG
Br J Pharmacol; 1998 Apr; 123(7):1325-30. PubMed ID: 9579726
[TBL] [Abstract][Full Text] [Related]
14. Stopped-flow analysis of CO and NO binding to inducible nitric oxide synthase.
Abu-Soud HM; Wu C; Ghosh DK; Stuehr DJ
Biochemistry; 1998 Mar; 37(11):3777-86. PubMed ID: 9521697
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of arginase in rat and rabbit alveolar macrophages by N omega-hydroxy-D,L-indospicine, effects on L-arginine utilization by nitric oxide synthase.
Hey C; Boucher JL; Vadon-Le Goff S; Ketterer G; Wessler I; Racké K
Br J Pharmacol; 1997 Jun; 121(3):395-400. PubMed ID: 9179379
[TBL] [Abstract][Full Text] [Related]
16. Recombinant arginine deiminase reduces inducible nitric oxide synthase iNOS-mediated neurotoxicity in a coculture of neurons and microglia.
Yu HH; Wu FL; Lin SE; Shen LJ
J Neurosci Res; 2008 Oct; 86(13):2963-72. PubMed ID: 18627024
[TBL] [Abstract][Full Text] [Related]
17. Two modes of binding of N-hydroxyguanidines to NO synthases: first evidence for the formation of iron-N-hydroxyguanidine complexes and key role of tetrahydrobiopterin in determining the binding mode.
Lefèvre-Groboillot D; Frapart Y; Desbois A; Zimmermann JL; Boucher JL; Gorren AC; Mayer B; Stuehr DJ; Mansuy D
Biochemistry; 2003 Apr; 42(13):3858-67. PubMed ID: 12667076
[TBL] [Abstract][Full Text] [Related]
18. Accessibility of endothelial and inducible nitric oxide synthase to the intracellular citrulline-arginine regeneration pathway.
Shen LJ; Beloussow K; Shen WC
Biochem Pharmacol; 2005 Jan; 69(1):97-104. PubMed ID: 15588718
[TBL] [Abstract][Full Text] [Related]
19. Substituted N-phenylisothioureas: potent inhibitors of human nitric oxide synthase with neuronal isoform selectivity.
Shearer BG; Lee S; Oplinger JA; Frick LW; Garvey EP; Furfine ES
J Med Chem; 1997 Jun; 40(12):1901-5. PubMed ID: 9191968
[TBL] [Abstract][Full Text] [Related]
20. L-arginine binding to human inducible nitric oxide synthase: an antisymmetric funnel route toward isoform-specific inhibitors?
Floquet N; Hernandez JF; Boucher JL; Martinez J
J Chem Inf Model; 2011 Jun; 51(6):1325-35. PubMed ID: 21574590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
